Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Natural Killer Cells Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Natural Killer Cells Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Natural Killer Cells Therapeutics Overall Market Size
2.1 Global Natural Killer Cells Therapeutics Market Size: 2021 VS 2028
2.2 Global Natural Killer Cells Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Natural Killer Cells Therapeutics Players in Global Market
3.2 Top Global Natural Killer Cells Therapeutics Companies Ranked by Revenue
3.3 Global Natural Killer Cells Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Natural Killer Cells Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Natural Killer Cells Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Natural Killer Cells Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Natural Killer Cells Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Natural Killer Cells Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Natural Killer Cells Therapeutics Market Size Markets, 2021 & 2028
4.1.2 NK Cell Therapies
4.1.3 NK Cell Directed Antibodies
4.2 By Type - Global Natural Killer Cells Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Natural Killer Cells Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Natural Killer Cells Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Natural Killer Cells Therapeutics Market Size, 2021 & 2028
5.1.2 Research Centers & Institutes
5.1.3 Hospitals
5.1.4 Others
5.2 By Application - Global Natural Killer Cells Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Natural Killer Cells Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Natural Killer Cells Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Natural Killer Cells Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Natural Killer Cells Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Natural Killer Cells Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Natural Killer Cells Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Natural Killer Cells Therapeutics Revenue, 2017-2028
6.3.2 US Natural Killer Cells Therapeutics Market Size, 2017-2028
6.3.3 Canada Natural Killer Cells Therapeutics Market Size, 2017-2028
6.3.4 Mexico Natural Killer Cells Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Natural Killer Cells Therapeutics Revenue, 2017-2028
6.4.2 Germany Natural Killer Cells Therapeutics Market Size, 2017-2028
6.4.3 France Natural Killer Cells Therapeutics Market Size, 2017-2028
6.4.4 U.K. Natural Killer Cells Therapeutics Market Size, 2017-2028
6.4.5 Italy Natural Killer Cells Therapeutics Market Size, 2017-2028
6.4.6 Russia Natural Killer Cells Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Natural Killer Cells Therapeutics Market Size, 2017-2028
6.4.8 Benelux Natural Killer Cells Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Natural Killer Cells Therapeutics Revenue, 2017-2028
6.5.2 China Natural Killer Cells Therapeutics Market Size, 2017-2028
6.5.3 Japan Natural Killer Cells Therapeutics Market Size, 2017-2028
6.5.4 South Korea Natural Killer Cells Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Natural Killer Cells Therapeutics Market Size, 2017-2028
6.5.6 India Natural Killer Cells Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Natural Killer Cells Therapeutics Revenue, 2017-2028
6.6.2 Brazil Natural Killer Cells Therapeutics Market Size, 2017-2028
6.6.3 Argentina Natural Killer Cells Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Natural Killer Cells Therapeutics Revenue, 2017-2028
6.7.2 Turkey Natural Killer Cells Therapeutics Market Size, 2017-2028
6.7.3 Israel Natural Killer Cells Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Natural Killer Cells Therapeutics Market Size, 2017-2028
6.7.5 UAE Natural Killer Cells Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Affimed
7.1.1 Affimed Corporate Summary
7.1.2 Affimed Business Overview
7.1.3 Affimed Natural Killer Cells Therapeutics Major Product Offerings
7.1.4 Affimed Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Affimed Key News
7.2 Celgene Corporation
7.2.1 Celgene Corporation Corporate Summary
7.2.2 Celgene Corporation Business Overview
7.2.3 Celgene Corporation Natural Killer Cells Therapeutics Major Product Offerings
7.2.4 Celgene Corporation Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Celgene Corporation Key News
7.3 Fate Therapeutics
7.3.1 Fate Therapeutics Corporate Summary
7.3.2 Fate Therapeutics Business Overview
7.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Major Product Offerings
7.3.4 Fate Therapeutics Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Fate Therapeutics Key News
7.4 Fortress Biotech
7.4.1 Fortress Biotech Corporate Summary
7.4.2 Fortress Biotech Business Overview
7.4.3 Fortress Biotech Natural Killer Cells Therapeutics Major Product Offerings
7.4.4 Fortress Biotech Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Fortress Biotech Key News
7.5 Glycostem Therapeutics
7.5.1 Glycostem Therapeutics Corporate Summary
7.5.2 Glycostem Therapeutics Business Overview
7.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Major Product Offerings
7.5.4 Glycostem Therapeutics Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Glycostem Therapeutics Key News
7.6 Innate Pharma
7.6.1 Innate Pharma Corporate Summary
7.6.2 Innate Pharma Business Overview
7.6.3 Innate Pharma Natural Killer Cells Therapeutics Major Product Offerings
7.6.4 Innate Pharma Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Innate Pharma Key News
7.7 Nantkwest
7.7.1 Nantkwest Corporate Summary
7.7.2 Nantkwest Business Overview
7.7.3 Nantkwest Natural Killer Cells Therapeutics Major Product Offerings
7.7.4 Nantkwest Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Nantkwest Key News
7.8 Nkarta Therapeutics
7.8.1 Nkarta Therapeutics Corporate Summary
7.8.2 Nkarta Therapeutics Business Overview
7.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Major Product Offerings
7.8.4 Nkarta Therapeutics Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Nkarta Therapeutics Key News
7.9 NKT Therapeutics
7.9.1 NKT Therapeutics Corporate Summary
7.9.2 NKT Therapeutics Business Overview
7.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Major Product Offerings
7.9.4 NKT Therapeutics Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
7.9.5 NKT Therapeutics Key News
7.10 Ziopharm Oncology
7.10.1 Ziopharm Oncology Corporate Summary
7.10.2 Ziopharm Oncology Business Overview
7.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Major Product Offerings
7.10.4 Ziopharm Oncology Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
7.10.5 Ziopharm Oncology Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer